Clinical trials
ALL, Childhood clinical trials
Below are recruiting all, childhood clinical trials, each written for real people, not researchers. We’re tracking 413 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05857969RecruitingPhase 1
Testing cancer drug response on removed tumor tissue
This early study uses tumor tissue (or bone marrow from blood cancers) and performs lab tests to see which cancer drugs may work better for each person. It also collects genetic information from blood or a saliva swab to help understand why cancers respond differently.
Miami, FloridaAges 1 day–21 years - NCT06674811Recruiting
Childhood cancer surgery recovery study
This study looks at how children and young adults recover after surgery for solid tumors. It also includes their caregivers to understand how resilience affects recovery.
Rochester, MinnesotaAges 3–25 - NCT05504772Recruiting
Personalized genetic testing for children with cancer
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
AdelaideAges birth–25 years - NCT06575296RecruitingPhase 1
Revumenib after stem cell transplant for acute leukemia
This trial tests a drug called revumenib to help keep leukemia from coming back after a stem cell transplant. It is for people with specific genetic types of acute leukemia who have recently had or will soon have a transplant.
Duarte, CaliforniaAges 2 years+ - NCT06247787RecruitingPhase 1
Imetelstat plus chemo for relapsed leukemia in kids
This trial tests a new drug called imetelstat combined with two chemotherapy drugs (fludarabine and cytarabine) for children and teens with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or juvenile myelomonocytic leukemia (JMML) that has come back or not responded to treatment. The goal is to find the safest dose of imetelstat and see if it helps control the cancer.
Birmingham, AlabamaAges 1–18 - NCT06208657RecruitingPhase 1/Phase 2
Personalized cancer therapy for kids and teens
This trial tests personalized cancer treatments for children and teens whose cancer has not responded to standard therapy. It uses information from precision medicine studies to match the right drug to each child's tumor.
Newcastle, New South WalesAges birth–21 years - NCT02402244Recruiting
Caring registry study for children and young people with cancer
This study keeps a careful record of children, teens, and young adults with cancer (and some related growths) and may follow them over time. It helps researchers better track outcomes and future contact so care can improve.
Birmingham, AlabamaAges Up to 25 years - NCT05606731Recruiting
Family coaching to help prevent childhood weight gain
This study offers a family-focused program for Latino adult caregivers of young children to help prevent childhood obesity. If your child is already overweight, the program may help you learn practical ways to support healthier habits as a family.
Los Angeles, CaliforniaAges 2 years+ - NCT07315009Recruiting
Active Fundament: Improving early childhood care
This study looks at how to make early childhood education and care better for children. It focuses on children and the professionals who work with them.
Maastricht, LimburgAges 2 years+ - NCT07222735RecruitingPhase 1
CAR T cells and radiation for children with sarcoma
This trial tests a combination of targeted radiation and special immune cells (CAR T cells) for children and young adults whose bone or soft tissue sarcoma has come back or not responded to standard treatments. The CAR T cells are made from your own blood cells and are designed to attack a protein called B7-H3 found on the sarcoma cells.
Memphis, TennesseeAges Up to 21 years - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT06915727RecruitingPhase 3
Testing an imaging drug to see tumors in children having surgery
This study tests a special imaging drug called pafolacianine (Cytalux) that helps doctors see tumors more clearly during surgery. It is for children and teens who have a solid tumor in the body and are already scheduled for tumor removal or biopsy.
Rochester, MinnesotaAges 6 months–17 years - NCT06609473Recruiting
Heart-healthy food program for childhood cancer survivors
This study tests a program that helps families get healthy food to lower heart risks in children who have finished cancer treatment. It is for survivors who have at least one heart risk factor and whose family has trouble getting enough food.
Boston, MassachusettsAges Up to 18 years - NCT04702321Recruiting
Study genetic risks for childhood cancer complications in Switzerland
This study looks at genetic factors to understand why some children who had cancer develop later complications. It uses stored samples and information from a Swiss biobank to help researchers identify higher-risk children.
GenevaAges Up to 21 years - NCT04661449Recruiting
Lifestyle program for babies born larger than expected
This trial looks at whether a structured lifestyle program improves health and development outcomes for babies who were born larger than expected (large-for-gestational-age). If you qualify, the study may guide caregiver and family habits to support your child’s early outcomes.
Shanghai, Shanghai MunicipalityAges 1 day–1 month - NCT04746209RecruitingPhase 2
Blinatumomab after transplant for high-risk B-ALL patients
This trial tests blinatumomab, an immune therapy, in young people with B-cell acute lymphoblastic leukemia (B-ALL) after their transplant or when they are getting ready for transplant. The goal is to lower the chance of the leukemia coming back by targeting remaining leukemia cells.
Milwaukee, WisconsinAges Up to 25 years - NCT04284189Recruiting
Aftercare study for survivors of childhood cancer in Switzerland
This study looks at follow-up care needs for people who survived childhood cancer, especially those in the later teen/adult years. You may be invited to complete questionnaires so the study team can understand and improve long-term aftercare.
AarauAges 16 years+ - NCT02208141Recruiting
Child body growth study with planned surgery
This study follows children’s body growth and fat (adipose) tissue as part of a planned surgical procedure. It aims to improve understanding of how fat tissue develops in childhood and what factors may affect health later.
Leipzig, SaxonyAges Any age - NCT04491344Recruiting
Study of childhood weight and body fat in clinic patients
This is a university study that looks at children who are already being seen in an outpatient clinic for excess body fat or weight concerns. If you/your child can give consent, the study collects information to better understand childhood obesity.
Leipzig, SaxonyAges 1 month–18 years - NCT07855302RecruitingPhase 1
CAR T-cell therapy for young people with lupus
This trial tests a treatment that uses a patient's own immune cells, modified to target and calm the overactive immune system causing lupus. It is for young people whose lupus is active despite trying several standard treatments.
SeoulAges Up to 25 years - NCT06153147Recruiting
Kidney & blood pressure in childhood cancer survivors
This study looks at kidney health and blood pressure in childhood cancer survivors. If you finished high-risk cancer therapy about 3 years ago, researchers want to see how your kidneys and blood pressure are doing now.
Toronto, OntarioAges Up to 19 years - NCT03604627Recruiting
Checking coronary calcium to study late heart blood vessel changes
This study looks at coronary calcium (a signal seen on heart scans) to help measure early or late heart blood-vessel problems in people who had cancer treatment as children or young adults. The goal is to better understand who may be at higher risk years later, especially after radiation or certain chemotherapy.
Villejuif, Val De MarneAges 18 years+ - NCT06457412Recruiting
Program for Helping Children with Severe Obesity
This study tests a program designed to help children ages 6 to 12 with severe obesity. It focuses on lifestyle changes like healthy eating and physical activity to improve your child's health.
CórdobaAges 6–12 - NCT07830134Recruiting
Brain training for childhood medulloblastoma survivors
This study tests a brain-training method that uses real-time feedback to help improve memory and thinking in young people who survived medulloblastoma. It may help with everyday tasks like remembering things and staying focused.
Memphis, TennesseeAges 10–25
Hear when a new ALL, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for all, childhood?
- Yes. Clin2 currently lists 413 recruiting all, childhood studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a all, childhood trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a all, childhood trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.